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bleeding was the commonest cause of UGIB. This difference might be explained by the high 
prevalence of chronic liver disease which in turn is as result of the high endemicity of hepatitis B 
virus in the Northern part of Nigeria and these other countries. This finding was also contrary to those 
reported from Europe, India and South America where erosive mucosal disease was identified as the 
second commonest cause of UGIB. Peptic ulcer disease was the second commonest cause of UGIB 
in this study (25.4%), contrary to the findings from the west where peptic ulcer disease which has 
been identified as the commonest cause of UGIB. Variceal bleeding was the third commonest cause 
of UGIB (11.9%) while gastric mass (1.5%) was the least common in this study. 
Conclusion: Antral mucosal erosions were the commonest cause of UGIB in our 
environment. NSAIDS intake was very high among the populace, especially in mucosal erosion group 
leading to high morbidity, absent from work and huge financial cost. It is recommended that serious 
awareness campaigns be mounted to educate the populace of the dangers inherent in indiscriminate 
use of NSAIDS in our society  
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Breast cancer (BC) continues to remain the most lethal malignancy in women across the 
world. A number of studies have suggested that there are epidemiological differences between BC 
among women in Europe and Africa. In Europe, the incidence is five times higher than that in Africa. 
Risk factors such as menopause, oral contraceptive use, cigarette smoking, and family history of 
breast cancer have been shown to have different relations to BC among blacks and whites. 
Aim: to uncover some of the epidemiological similarities and differences in breast cancers 
between white European women and black African women. 
Materials and methods: Materials and Methods: Due to lack of a reliable population 
statistics and absence of population-based cancer registries were studied several epidemiological 
studies done in Nigeria and Tanzania mostly hospital-based. 
Result: The mean age at presentation varies between Africa and Europe, he is 48 years in 
Africa and approximately two-thirds are premenopausal. On the contrary, the majority of women 
present at postmenopause in Europe. That differences in the epidemiology of BC among races could 
partly be attributed to endogenous hormones. In comparison to Caucasians, African women had 18% 
higher levels of oestradiol in premenopausal age. These findings may explain the higher incidence of 
premenopausal BC among women of African origin. Histologically, ductal carcinoma is the 
commonest type of BC among women in Africa and Europe with similar frequency. However, 
medullary and mucinous carcinomas are more common in Africa than in Europe. In addition, more 
women have grade 3 tumours in Africa than in Europe. In Tanzania, for example, 56.4% have tumours 
with histological grade 3, while, in Nigeria, 45,1% have grade 3 tumour. On the contrary, only 15,8% 
of Ukrainian women have a grade 3 tumour. This may explain why the progression of BC more 
aggressive in African women than in European women. There is a significant difference in staging at 
the time of presentation between European women and their African counterparts. Most women in 
Africa present when the disease is at an advanced stage. In a study in East Africa, more than 70% of 
the patients presented at stage III or IV. However, in Europe, women are more likely to present when 
the disease is still in its early stage. The reason for the advanced presentation in Africa could be due 
to lack of health care coverage especially in remote rural areas and poverty as healthcare is not free 
in most countries. This is in contrast to Ukraine where health care is not only free, but also regular 
screening is available to women of certain ages. This increases the probability of detecting BC at a 
very early stage. As a result, most women in Africa have mastectomy and adjuvant hormonal therapy 
or chemotherapy and many others only receive palliative care because the tumour is advanced and 
inoperable. 
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Conclusion: the incidence of BC is still low in Africa compared to the incidence in Europe. 
This has largely been attributed to a protective reproductive history including late menarche, early 
menopause, high parity with prolonged breastfeeding. However, African women tend to present at an 
earlier age and the disease appears to be more aggressive than in their European counterparts. 
  
 
ADVANTAGES CARBON DIOXIDE LASER IN THE SURGICAL TREATMENT 
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Pigmented nevi are benign proliferations present at birth that consists of cells normally present 
in skin. Some nevi have a malignant potential. There is a lot of methods of treatment of this abnormal 
condition, namely surgical resection, cryosurgery, laser excision, the use of bleaching agents. Surgical 
method not impeded the spread of  nevi cells, what has the potential for malignancy. Non contact 
mode of excision with laser can reduce intraroperative wound contamination by tumor cells. For its 
universal properties the carbon dioxide (CO2) laser appears to be an excellent surgical instrument in 
oncologic surgery of skin lesions. 
Aim: To improve results of surgical treatment of congenital pigmented nevi by using CO2 
laser. 
Materials and methods: CO2 laser was used in treatment of 50 patients with pigmented 
nevus consisting of 24 (48%) males and 26 (52%) females with age ranges from 16 - 68 years. For 
local anesthesia 0,5% Sol. lidocaine was used The treatment effect was based on the surgical wound 
evaluation, the relative time of healing and possible local recurrence of the tumor after 3 months after 
surgery. 
Results: excision was made in 20 (40%) cases of nevi greater than1.5 cm diameter, and 30 
(60%) patients of nevi  ranging from 0.5 to 1.5 cm in diameter. In all patients, whom CO2 laser was 
used for excision of pigmented nevi, bleeding was absent during operation, injury of surrounding 
tissues was minimal and healing of wound was during 7-14 days, without infection complications. 
Improved visibility through better hemostasis provides greater confidence of complete excision and 
time saving. In 34 (68%) cases time needed for complete resection of lesions was less than 10 minutes. 
Time of healing was longer than 12 days in 8 cases (16,0%) . Local recurrence was observed only in 
two cases (4%). The probable cause of this  is the sealing of small blood vessels and lymph vessels 
by the CO2 laser which prevents tumor cells spreading. The advantages of the CO2 laser surgery 
were better hemostasis, precision of working, non-contact dissection (absence of the potential for 
malignancy), minimum traumatization of the surrounding tissues, reduced postoperative pain,  quick 
postoperative healing .  
Conclusion:  CO2 laser is an effective method of surgical treatment of congenital pigmented 
nevi. 
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Colorectal carcinoma (CRC) is the third most common cancer worldwide and the third most 
common cause of deaths from cancer in both sexes in industrialized nations. The incidence varies 
according to geographical location with the highest rates reported from Northern and Western Europe, 
USA.  The incidence of CRC in USA reaches 57,0 per 100 000 population, in Ukraine, according to 
the National Cancer Registry in 2013 was 44,0 per 100 000 population, in the Sumy region, this date 
was 43,1/100 000. Although the highest incidence of CRC in USA is seen among African Americans 
(71,0/100 000) , CRC is an uncommon malignancy in Nigeria. Studies that have been published from 
